Perfil de la empresa · Healthcare

Jiangzhong Pharmaceutical Co Ltd

600750 · Shanghái
País / Región
China
Fecha de salida a bolsa
29 de agosto de 1996
Empleados
4352
Sitio web
www.jzjt.com
Buffett Score
84/100
Excelente
Capitalización14,32 mil M CNY
Ingresos (TTM)4010,67 M CNY
EBITDA1100,58 M CNY
Margen neto21,84 %
ROE20,95 %
PER (TTM)16,21
PER previsto18,62
BPA1,39 CNY
Rentabilidad por dividendo6,19 %
Rango de 52 semanas21,05 CNY – 27,83 CNY

Datos de EODHD, mostrados en la moneda de reporte; solo a título informativo, no constituye asesoramiento de inversión.

China Resources Jiangzhong Pharmaceutical Co.,Ltd engages in the manufacture of pharmaceutical products in China. The company offers OTC products, including stomach-strengthening and digestion-promoting tablets, lactobacillus tablets, triple live bifidobacterium enteric-coated capsules, compound fresh bamboo juice liquid, compound coral lozenges, multivitamin tablets, fritillaria and loquat capsules, bezoar and snake gallbladder fritillaria liquid, and compound gold melon seed. It also provides health consumer and other products, such as nourishing, tonics, rehabilitation nutrition, gastrointestinal health, and liver health products. In addition, the company offers prescription drugs comprising traditional Chinese medicine products, which includes Shenbao capsules, Paishi granules, Huangba Shengmai drink, Bazhen Yimu capsules; chemical medicine products, such as lumbrokinase enteric-coated capsules, Rabeprazole sodium enteric-coated tablets, chloroprocaine hydrochloride, etc.; and medicinal materials which includes codonopsis pilosula. The company was formerly known as Jiang Zhong Pharmaceutical Co.,Ltd and changed its name to China Resources Jiangzhong Pharmaceutical Co.,Ltd in January 2025. China Resources Jiangzhong Pharmaceutical Co.,Ltd was founded in 1996 and is headquartered in Nanchang, China.

Historia

PróximamenteEsta sección se está completando; vuelve pronto.

Posición en el sector

PróximamenteEsta sección se está completando; vuelve pronto.

Aún no hay análisis sobre este valor en tu idioma.